Detailed View
IMRX - Immuneering Corporation
Latest filing: 2026-03-31 | Reporting: gaap
Market Cap
357,776,640
Adj EBIT (TTM)
-59,226,351
Enterprise Value
310,455,074
Last Price
5.53
Earnings Yield
-19.08%
Return on Capital
-29.20%
Capital
202,831,279
1Y Price Chart
Last Price: -
1Y Change: -
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-03-31 | 10-Q | 2026 | 0 | -15,335,034 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 0 | 31,974,477 |
| 2025-09-30 | 10-Q | 2025 | 0 | -45,623,250 |
| 2025-06-30 | 10-Q | 2025 | 0 | -30,242,544 |
| 2025-03-31 | 10-Q | 2025 | 0 | -15,484,652 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 0 | 27,007,093 |
| 2024-09-30 | 10-Q | 2024 | 0 | -45,513,246 |
| 2024-06-30 | 10-Q | 2024 | 0 | -30,239,498 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.